The good anti-tumor activity of ICOS-Fc conjugated on the NB surface might be ascribed to its high valence compared to the Ig-like bivalency of ICOS-Fc, which is expected to increase the level of ICOSL crosslinking and stimulation. The gene discussed is ICOSLG; the disease is neoplasm.